Quantcast

Latest Therapeutic hypothermia Stories

2009-02-03 13:52:00

SAN DIEGO, Feb. 3 /PRNewswire/ -- BeneChill, Inc. (www.benechill.com) today announced the start of the PRINCE (Pre-Resuscitation Intra-Nasal Cooling Effectiveness) study. This randomized study will determine whether intra-nasal cooling using BeneChill's RhinoChill device during resuscitation increases patient resuscitation and survival rates. The PRINCE study is being conducted as a post-market approval study in Europe. The company received CE marking for the RhinoChill system in 2007. The...

2009-02-03 06:30:00

IRVINE, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Alsius Corporation (Nasdaq: ALUS), the worldwide leader in intravascular temperature management (IVTM(TM)) therapies for critically ill patients, today announced that it is prepared to respond aggressively to the patent lawsuit brought against it by ZOLL Circulation, Inc., a subsidiary of ZOLL Medical Corporation (Nasdaq: ZOLL). Alsius was sued by ZOLL based on two temperature management patents ZOLL purchased from a defunct competitor of...

2009-01-29 08:00:00

First Responders Leading the Charge of Cooling Therapy for Cardiac Patients SAN DIEGO, Jan. 29 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext US: CXM) and its operating unit InnerCool Therapies today reported on the growing trend of the country's first responders leading the charge and adopting therapeutic hypothermia protocols for cardiac arrest patients. Newly emerging protocols recommend that cardiac arrest patients be quickly cooled, beginning even before they reach the...

2009-01-27 11:59:00

SAN DIEGO, Jan. 27 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext US: CXM) and its operating unit InnerCool Therapies today announced the launch of InnerCool's newly redesigned website at www.innercool.com. The updated and expanded website highlights InnerCool's new RapidBlue(TM) high-performance endovascular temperature modulation system, its CoolBlue(TM) surface system, and CoolConnect Adapters to allow CoolBlue surface pads to be used with other hypothermia consoles....

2009-01-26 17:44:00

SAN DIEGO, Jan. 26 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext US: CXM) today reported that Ronald I. Simon (age 70) has retired from the Company's Board of Directors. The resignation reduces the size of Cardium's board to seven directors. "We thank Dr. Simon for his service to the Board and wish him all the best in the years ahead," stated Christopher J. Reinhard, Chairman and Chief Executive Officer of Cardium Therapeutics. (Logo:...

2009-01-14 15:56:27

Sub-zero U.S. temperatures can put people at risk for hypothermia, or abnormally low body temperature, federal health officials said. Health officials at the Centers for Disease Control and Prevention said that when exposed to cold temperatures, the body begins to lose heat faster than it can be produced, which can result in hypothermia. Body temperature that is too low affects the brain, making the victim unable to think clearly or move well. Hypothermia occurs most commonly at very cold...

2008-12-15 08:00:00

SAN DIEGO, Dec. 15 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext US: CXM) announced that its operating unit InnerCool Therapies, Inc. was awarded a new supplier contract with Novation LLC to introduce InnerCool's RapidBlue endovascular patient temperature modulation system into Novation's extensive network of member health care systems, which includes thousands of hospitals throughout the United States. The agreement, effective January 1, 2009, has a three-year initial term...

2008-12-09 05:00:00

Best hospitals adhere to trend in medicine favoring non-invasive interventions that minimize needless complications LOUISVILLE, Colo., Dec. 9 /PRNewswire/ -- The nation's top-rated heart programs continue to favor the non-invasive, safe and technologically advanced Arctic Sun Temperature Management System from Medivance for cooling critically ill patients. Cooling comatose cardiac arrest survivors is an evidence-based standard of care recommended by the American Heart Association....

2008-12-05 08:00:00

SAN DIEGO, Dec. 5 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext: CXM) and its operating unit InnerCool Therapies today reported on New York City's adoption of procedures designed to promote temperature modulation therapy for cardiac arrest patients, as featured in an article in The New York Times. The article, "City Pushes Cooling Therapy," dated December 4, 2008, reports that New York City ambulances will now be required to transport cardiac arrest patients to hospitals...

2008-11-10 18:00:05

SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- Cardium Therapeutics today reported financial results and highlights for its third quarter ended September 30, 2008, and outlined revised business strategies for its three operating units: (1) InnerCool Therapies, (2) Tissue Repair Company, and (3) Cardium Biologics. (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO) InnerCool Therapies, Inc. The Company recently announced 510(k) clearance from the...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related